Back to list

Iambic

Developer of therapeutic discovery quantum molecular simulation engine designed to accelerate molecular discovery.
Drug Discovery 📍 San Diego, CA Founded 2019
Current Valuation
$648M
as of 2026-Q2
PRIVATE
Developer of therapeutic discovery quantum molecular simulation engine designed to accelerate molecular discovery.

Company Profile

Founded
2019
HQ
San Diego, CA
Employees
153
Total Raised
$354.77M
Last Round
Series B — $27.77M (Apr 2026)
IPO Status
private

Fundraising Status

Series B · $27.77M · 4 mo ago
privateTotal raised $354.77M

Secondary Market

Implied price / share
$1.25
Last round price / share
$3.26
vs last round
-61.7%
Open interest
3
Last round price vs secondary price
Last round vs current secondary price per share$3.26Last round$1.25Current
Secondary price return by period
Secondary market period returns3-month+25.0%6-month+25.0%1-year+25.0%All-time+25.0%
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series B$27.77MApr 2026$648M
Artificial IntelligenceMachine LearningSoftwareTherapeutics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2026-Q2. Refreshed quarterly.